A phase ii trial of cetuximab, gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma

Gastrointestinal Cancer Research

Volumn 6, Issue 4 SUPPL.1, 2013, Pages 2-9

  Cetin, Volkan ^a   Piperdi, Bilal ^b   Bathini, Venu ^c   Walsh, William V ^c   Yunus, Shakeeb ^c   Tseng, Jennifer F ^d   Whalen, Giles F ^c   Wassef, Wahid Y ^c   Kadish, Sidney P ^c   Fitzgerald, Thomas J ^c   Mikule, Christine ^c   Wang, Yuxia ^c   Grossman, Steven R ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CETUXIMAB; FLUOROURACIL; GEMCITABINE;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONSTIPATION; CONTINUOUS INFUSION; COUGHING; DIARRHEA; DIZZINESS; DRY SKIN; EPISTAXIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEARTBURN; HEMATOLOGIC DISEASE; HUMAN; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; LOADING DRUG DOSE; MALE; MIDDLE AGED; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OPEN STUDY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PHASE 2 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; PRURITUS; RASH; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

EID: 84891641622     PISSN: 19347820     EISSN: 19347987     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta: American Cancer Society, 2010
2. Li D, Xie K, Wolff R, et al: Pancreatic cancer. Lancet 363:1049-1057, 2004
3. Hidalgo M: Pancreatic Cancer. N Engl J Med 362:1605-1617, 2010
4. Willett CG, Czito BG, Bendell JC, et al: Locally advanced pancreatic cancer. J Clin Oncol 23: 4538-44, 2005
5. Chang BW, Saif MW: Locally Advanced Pancreatic Adenocarcinoma: Where Are We and Where Are We Going? J Pancreas (Online) 12:101-105, 2011
6. Blackstock AW, Tepper JE, Niedwiecki D, et al: Cancer and Leukemia Group B (CALGB) 89805: Phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Int J Gastrointest Cancer 34:107- 116, 2003
7. Henry Q. Xiong, Arthur Rosenberg, et al: Cetux-imab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II trial. J Clin Oncol Vol 22:2610-2616, 2004
8. Moore MJ, Goldstein D, Hamm J, et al: Erlotinib improves survival when added to gemcitabine in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. ASCO Gastrointestinal Cancers Symposium, Miami, FL, January 27-29, 2005 (abstr 77)
9. Andriulli A, Festa V, Botteri E, et al: Neoadju-vant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol 19:1644-1662, 2012
10. Huguet F, Girard N, Guerche CS, et al: Chemo-radiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review. J Clin Oncol 27:2269-2277, 2009
11. Sultana A, Tudur Smith C, Cunningham D et al: Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer 96:1183-2269, 2007
12. Krzyzanowska MK, Weeks JC, Earle CC: Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol 21:3409-3414, 2003
13. Katz MH, Pisters PW, Evans DB, et al: Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833-846, 2008
14. Mamon HJ, Niedzwiecki D, Hollis D, et al: A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmeta-static pancreatic adenocarcinoma: Cancer and Leukemia Group B (CALGB) 80003. Cancer 117:2620-2628, 2011